Perdagangan Alimera Sciences, Inc. - ALIM CFD
Tambah ke favorit- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.26 | ||||||||
Biaya inap posisi Long
Long position overnight fee
Kunjungi platform | -0.025457% | ||||||||
Biaya inap posisi short
Short position overnight fee
Kunjungi platform | 0.003235% | ||||||||
Waktu biaya inap | 21:00 (UTC) | ||||||||
Kuantitas min. yang diperdagangkan | 1 | ||||||||
Mata uang | USD | ||||||||
Margin | 20% | ||||||||
Bursa efek | United States of America | ||||||||
Komisi perdagangan | 0% |
*Information provided by Capital.com
Prev. Close* | 2.57 |
Open* | 2.55 |
1-Year Change* | -56.11% |
Day's Range* | 2.55 - 2.78 |
52 wk Range | 1.30-7.92 |
Average Volume (10 days) | 291.73K |
Average Volume (3 months) | 12.95M |
Market Cap | 19.84M |
P/E Ratio | -100.00K |
Shares Outstanding | 7.40M |
Revenue | 55.78M |
EPS | -2.44 |
Dividend (Yield %) | N/A |
Beta | 1.39 |
Next Earnings Date | Jul 25, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jun 2, 2023 | 2.57 | 0.06 | 2.39% | 2.51 | 2.66 | 2.50 |
Jun 1, 2023 | 2.52 | -0.08 | -3.08% | 2.60 | 2.60 | 2.51 |
May 31, 2023 | 2.67 | 0.19 | 7.66% | 2.48 | 2.67 | 2.48 |
May 30, 2023 | 2.52 | 0.05 | 2.02% | 2.47 | 2.55 | 2.47 |
May 26, 2023 | 2.49 | 0.08 | 3.32% | 2.41 | 2.52 | 2.35 |
May 25, 2023 | 2.48 | -0.02 | -0.80% | 2.50 | 2.51 | 2.37 |
May 24, 2023 | 2.41 | 0.23 | 10.55% | 2.18 | 2.42 | 2.14 |
May 23, 2023 | 2.32 | -0.19 | -7.57% | 2.51 | 2.55 | 2.21 |
May 22, 2023 | 2.45 | 0.28 | 12.90% | 2.17 | 2.72 | 2.15 |
May 19, 2023 | 2.23 | 0.12 | 5.69% | 2.11 | 2.30 | 2.02 |
May 18, 2023 | 2.34 | -0.26 | -10.00% | 2.60 | 3.05 | 2.26 |
May 17, 2023 | 1.93 | 0.11 | 6.04% | 1.82 | 1.94 | 1.78 |
May 16, 2023 | 1.79 | 0.21 | 13.29% | 1.58 | 1.92 | 1.58 |
May 15, 2023 | 1.57 | -0.03 | -1.88% | 1.60 | 1.68 | 1.56 |
May 12, 2023 | 1.56 | -0.05 | -3.11% | 1.61 | 1.64 | 1.55 |
May 11, 2023 | 1.57 | 0.02 | 1.29% | 1.55 | 1.64 | 1.48 |
May 10, 2023 | 1.52 | -0.11 | -6.75% | 1.63 | 1.85 | 1.51 |
May 9, 2023 | 1.63 | -0.14 | -7.91% | 1.77 | 1.77 | 1.63 |
May 8, 2023 | 1.73 | -0.06 | -3.35% | 1.79 | 1.80 | 1.73 |
May 5, 2023 | 1.83 | -0.05 | -2.66% | 1.88 | 2.04 | 1.76 |
Alimera Sciences, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Wednesday, July 12, 2023 | ||
Time (UTC) 13:30 | Country US
| Event Alimera Sciences Inc Annual Shareholders Meeting Alimera Sciences Inc Annual Shareholders MeetingForecast -Previous - |
Tuesday, July 25, 2023 | ||
Time (UTC) 12:30 | Country US
| Event Q2 2023 Alimera Sciences Inc Earnings Release Q2 2023 Alimera Sciences Inc Earnings ReleaseForecast -Previous - |
Monday, November 13, 2023 | ||
Time (UTC) 13:30 | Country US
| Event Q3 2023 Alimera Sciences Inc Earnings Release Q3 2023 Alimera Sciences Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 54.129 | 59.029 | 50.82 | 53.943 | 46.599 |
Revenue | 54.129 | 59.029 | 50.82 | 53.943 | 46.599 |
Cost of Revenue, Total | 7.977 | 7.03 | 6.941 | 6.626 | 4.308 |
Gross Profit | 46.152 | 51.999 | 43.879 | 47.317 | 42.291 |
Total Operating Expense | 65.769 | 57.438 | 51.321 | 59.217 | 58.035 |
Selling/General/Admin. Expenses, Total | 38.858 | 35.843 | 32.036 | 38.958 | 38.042 |
Research & Development | 16.228 | 13.778 | 9.668 | 10.992 | 11.274 |
Depreciation / Amortization | 2.706 | 2.579 | 2.676 | 2.641 | 2.645 |
Unusual Expense (Income) | 0 | -1.792 | 0 | 1.766 | |
Operating Income | -11.64 | 1.591 | -0.501 | -5.274 | -11.436 |
Interest Income (Expense), Net Non-Operating | -5.789 | -4.997 | -4.906 | -4.953 | -4.84 |
Net Income Before Taxes | -18.079 | -3.934 | -5.407 | -10.227 | -16.276 |
Net Income After Taxes | -18.107 | -4.372 | -5.339 | -10.443 | -16.382 |
Net Income Before Extra. Items | -18.107 | -4.372 | -5.339 | -10.443 | -16.382 |
Net Income | -18.107 | -4.372 | -5.339 | -10.443 | -16.382 |
Income Available to Common Excl. Extra. Items | -18.107 | -4.372 | -5.339 | -10.443 | 21.948 |
Income Available to Common Incl. Extra. Items | -18.107 | -4.372 | -5.339 | -10.443 | 21.948 |
Diluted Net Income | -18.107 | -4.372 | -5.339 | -10.443 | 21.948 |
Diluted Weighted Average Shares | 6.99685 | 6.59524 | 5.11766 | 4.7702 | 5.91587 |
Diluted EPS Excluding Extraordinary Items | -2.58788 | -0.6629 | -1.04325 | -2.18921 | 3.71002 |
Diluted Normalized EPS | -2.58788 | -0.83951 | -1.04325 | -2.18921 | 3.90406 |
Other Operating Expenses, Total | |||||
Total Extraordinary Items | 0 | 0 | |||
Total Adjustments to Net Income | 0 | 38.33 | |||
Other, Net | -0.65 | -0.528 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total revenue | 13.546 | 14.029 | 13.598 | 14.604 | 11.898 |
Revenue | 13.546 | 14.029 | 13.598 | 14.604 | 11.898 |
Cost of Revenue, Total | 2.028 | 2.125 | 2.006 | 2.166 | 1.68 |
Gross Profit | 11.518 | 11.904 | 11.592 | 12.438 | 10.218 |
Total Operating Expense | 16.848 | 16.137 | 17.009 | 16.578 | 16.045 |
Selling/General/Admin. Expenses, Total | 9.975 | 9.099 | 9.856 | 9.81 | 10.093 |
Research & Development | 4.164 | 4.23 | 4.483 | 3.932 | 3.583 |
Depreciation / Amortization | 0.681 | 0.683 | 0.664 | 0.67 | 0.689 |
Operating Income | -3.302 | -2.108 | -3.411 | -1.974 | -4.147 |
Interest Income (Expense), Net Non-Operating | -1.68 | -1.621 | -1.567 | -1.345 | -1.256 |
Net Income Before Taxes | -4.968 | -3.781 | -5.245 | -3.098 | -5.955 |
Net Income After Taxes | -4.968 | -3.78 | -5.257 | -3.115 | -5.955 |
Net Income Before Extra. Items | -4.968 | -3.78 | -5.257 | -3.115 | -5.955 |
Net Income | -4.968 | -3.78 | -5.257 | -3.115 | -5.955 |
Income Available to Common Excl. Extra. Items | -4.982 | -3.78 | -5.257 | -3.115 | -5.955 |
Income Available to Common Incl. Extra. Items | -4.982 | -3.78 | -5.257 | -3.115 | -5.955 |
Diluted Net Income | -4.982 | -3.78 | -5.257 | -3.115 | -5.955 |
Diluted Weighted Average Shares | 7.03223 | 7.00032 | 6.99658 | 6.99971 | 6.99074 |
Diluted EPS Excluding Extraordinary Items | -0.70845 | -0.53998 | -0.75137 | -0.44502 | -0.85184 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.70845 | -0.53998 | -0.75137 | -0.44502 | -0.85184 |
Unusual Expense (Income) | 0 | 0 | 0 | ||
Other, Net | 0.014 | -0.052 | -0.267 | 0.221 | -0.552 |
Total Adjustments to Net Income | -0.014 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 29.413 | 42.16 | 34.906 | 32.745 | 34.848 |
Cash and Short Term Investments | 5.274 | 16.51 | 11.208 | 9.426 | 13.043 |
Cash & Equivalents | 5.274 | 16.51 | 11.208 | 9.426 | 13.043 |
Total Receivables, Net | 19.612 | 19.128 | 17.2 | 19.331 | 17.259 |
Accounts Receivable - Trade, Net | 19.612 | 19.128 | 17.2 | 19.331 | 17.259 |
Total Inventory | 1.605 | 2.679 | 2.746 | 1.39 | 2.405 |
Prepaid Expenses | 2.892 | 3.809 | 3.718 | 2.565 | 2.109 |
Other Current Assets, Total | 0.03 | 0.034 | 0.034 | 0.033 | 0.032 |
Total Assets | 42.602 | 58.52 | 50.855 | 50.309 | 54.108 |
Property/Plant/Equipment, Total - Net | 3.92 | 4.493 | 2.358 | 2.047 | 1.355 |
Property/Plant/Equipment, Total - Gross | 7.981 | 7.923 | 6.305 | 5.858 | 4.967 |
Accumulated Depreciation, Total | -4.061 | -3.43 | -3.947 | -3.881 | -3.612 |
Intangibles, Net | 8.957 | 10.897 | 12.838 | 14.783 | 16.723 |
Other Long Term Assets, Total | 0.129 | 0.137 | 0.753 | 0.734 | 1.182 |
Total Current Liabilities | 39.732 | 12.592 | 12.348 | 12.048 | 10.234 |
Accounts Payable | 10.088 | 8.706 | 7.461 | 7.077 | 6.355 |
Accrued Expenses | 3.998 | 3.617 | 3.197 | 4.716 | 3.643 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 25.646 | 0.269 | 1.69 | 0.255 | 0.236 |
Other Current Liabilities, Total | |||||
Total Liabilities | 63.41 | 61.125 | 58.833 | 54.754 | 51.386 |
Total Long Term Debt | 18.683 | 43.08 | 42.922 | 38.752 | 38.178 |
Long Term Debt | 18.683 | 43.08 | 42.408 | 38.658 | 37.873 |
Capital Lease Obligations | 0.514 | 0.094 | 0.305 | ||
Other Liabilities, Total | 4.995 | 5.453 | 3.563 | 3.954 | 2.974 |
Total Equity | -20.808 | -2.605 | -7.978 | -4.445 | 2.722 |
Preferred Stock - Non Redeemable, Net | 19.227 | 19.227 | 19.227 | 30.344 | 30.344 |
Common Stock | 0.07 | 0.069 | 0.057 | 0.05 | 0.701 |
Additional Paid-In Capital | 378.238 | 377.229 | 365.83 | 350.117 | 346.108 |
Retained Earnings (Accumulated Deficit) | -415.388 | -397.281 | -392.539 | -383.863 | -373.42 |
Other Equity, Total | -2.955 | -1.849 | -0.553 | -1.093 | -1.011 |
Total Liabilities & Shareholders’ Equity | 42.602 | 58.52 | 50.855 | 50.309 | 54.108 |
Total Common Shares Outstanding | 6.99551 | 6.93515 | 5.71937 | 4.96595 | 4.67193 |
Total Preferred Shares Outstanding | 0.6 | 0.6 | 0.6 | 0.61015 | 0.61015 |
Long Term Investments | 0.183 | 0.833 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 35.675 | 29.413 | 29.76 | 33.073 | 34.753 |
Cash and Short Term Investments | 13.086 | 5.274 | 5.514 | 7.859 | 9.946 |
Cash & Equivalents | 13.086 | 5.274 | 5.514 | 7.859 | 9.946 |
Total Receivables, Net | 18.433 | 19.612 | 19.142 | 20.319 | 18.776 |
Accounts Receivable - Trade, Net | 18.433 | 19.612 | 19.142 | 20.319 | 18.776 |
Total Inventory | 1.215 | 1.605 | 1.786 | 1.656 | 2.452 |
Prepaid Expenses | 2.91 | 2.892 | 3.29 | 3.208 | 3.546 |
Other Current Assets, Total | 0.031 | 0.03 | 0.028 | 0.031 | 0.033 |
Total Assets | 48.239 | 42.602 | 43.429 | 47.574 | 49.931 |
Property/Plant/Equipment, Total - Net | 3.757 | 3.92 | 3.87 | 3.938 | 4.343 |
Intangibles, Net | 8.479 | 8.957 | 9.446 | 9.935 | 10.419 |
Other Long Term Assets, Total | 0.131 | 0.129 | 0.118 | 0.126 | 0.134 |
Total Current Liabilities | 14.173 | 39.732 | 34.01 | 25.431 | 17.006 |
Accounts Payable | 9.669 | 10.088 | 8.706 | 7.614 | 6.604 |
Accrued Expenses | 4.241 | 3.998 | 3.661 | 3.316 | 3.046 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.263 | 25.646 | 21.643 | 14.501 | 7.356 |
Total Liabilities | 67.155 | 63.41 | 61.507 | 59.909 | 58.534 |
Total Long Term Debt | 44.312 | 18.683 | 22.492 | 29.297 | 36.245 |
Long Term Debt | 44.152 | 18.683 | 22.492 | 29.297 | 36.245 |
Capital Lease Obligations | 0.16 | ||||
Other Liabilities, Total | 8.67 | 4.995 | 5.005 | 5.181 | 5.283 |
Total Equity | -18.916 | -20.808 | -18.078 | -12.335 | -8.603 |
Preferred Stock - Non Redeemable, Net | 7.728 | 19.227 | 19.227 | 19.227 | 19.227 |
Common Stock | 0.074 | 0.07 | 0.07 | 0.07 | 0.07 |
Additional Paid-In Capital | 378.146 | 378.238 | 378.005 | 377.847 | 377.541 |
Retained Earnings (Accumulated Deficit) | -402.081 | -415.388 | -411.608 | -406.351 | -403.236 |
Other Equity, Total | -2.783 | -2.955 | -3.772 | -3.128 | -2.205 |
Total Liabilities & Shareholders’ Equity | 48.239 | 42.602 | 43.429 | 47.574 | 49.931 |
Total Common Shares Outstanding | 7.39159 | 6.99551 | 6.99802 | 6.99546 | 6.99265 |
Total Preferred Shares Outstanding | 0.012 | 0.6 | 0.6 | 0.6 | 0.6 |
Long Term Investments | 0.197 | 0.183 | 0.235 | 0.502 | 0.282 |
Other Current Liabilities, Total |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -18.107 | -4.372 | -5.339 | -10.443 | -16.382 |
Cash From Operating Activities | -9.975 | -3.224 | -2.193 | -4.152 | -11.553 |
Cash From Operating Activities | 2.706 | 2.579 | 2.676 | 2.641 | 2.645 |
Deferred Taxes | 0.116 | 0.61 | 0.031 | 0.454 | -0.653 |
Non-Cash Items | 2.621 | -0.692 | 1.829 | 3.377 | 7.084 |
Cash Taxes Paid | 0.232 | 0.112 | 0.11 | 0.239 | 0.239 |
Cash Interest Paid | 4.489 | 4.302 | 4.556 | 4.419 | 3.571 |
Changes in Working Capital | 2.689 | -1.349 | -1.39 | -0.181 | -4.247 |
Cash From Investing Activities | -0.255 | -0.621 | -0.62 | -0.174 | -0.175 |
Capital Expenditures | -0.255 | -0.621 | -0.62 | -0.174 | -0.175 |
Cash From Financing Activities | -0.302 | 9.823 | 3.882 | 0.869 | 0.95 |
Financing Cash Flow Items | -0.113 | 0 | -0.019 | -2.227 | -3.808 |
Issuance (Retirement) of Stock, Net | 0.1 | 10.044 | 0.049 | 0.902 | 0.085 |
Issuance (Retirement) of Debt, Net | -0.289 | -0.221 | 3.852 | 2.194 | 4.673 |
Foreign Exchange Effects | -0.708 | -0.676 | 0.714 | -0.159 | -0.248 |
Net Change in Cash | -11.24 | 5.302 | 1.783 | -3.616 | -11.026 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -4.968 | -18.107 | -14.327 | -9.07 | -5.955 |
Cash From Operating Activities | -2.209 | -9.975 | -9.724 | -7.811 | -6.213 |
Cash From Operating Activities | 0.681 | 2.706 | 2.023 | 1.359 | 0.689 |
Non-Cash Items | 0.507 | 2.621 | 2.095 | 1.318 | 1.027 |
Cash Taxes Paid | 0 | 0.232 | 0.224 | 0.182 | 0.018 |
Cash Interest Paid | 1.354 | 4.489 | 3.253 | 2.145 | 1.061 |
Changes in Working Capital | 1.571 | 2.689 | 0.485 | -1.418 | -1.974 |
Cash From Investing Activities | -0.009 | -0.255 | -0.171 | -0.041 | -0.149 |
Capital Expenditures | -0.009 | -0.255 | -0.171 | -0.041 | -0.149 |
Cash From Financing Activities | 9.998 | -0.302 | -0.109 | -0.164 | -0.062 |
Financing Cash Flow Items | -3.123 | -0.113 | |||
Issuance (Retirement) of Debt, Net | 2.373 | -0.289 | -0.164 | -0.204 | -0.062 |
Foreign Exchange Effects | 0.033 | -0.708 | -0.998 | -0.638 | -0.141 |
Net Change in Cash | 7.813 | -11.24 | -11.002 | -8.654 | -6.565 |
Issuance (Retirement) of Stock, Net | 10.748 | 0.1 | 0.055 | 0.04 | |
Deferred Taxes | 0.116 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Velan Capital Investment Management LP | Investment Advisor/Hedge Fund | 22.4131 | 1659654 | 1401901 | 2023-05-17 | MED |
Ocumension Therapeutics | Corporation | 15.4621 | 1144945 | 0 | 2023-04-24 | LOW |
Morgan Stanley & Co. LLC | Research Firm | 8.9243 | 660832 | 0 | 2023-03-31 | MED |
Caligan Partners, LP | Hedge Fund | 6.4657 | 478777 | 0 | 2023-05-17 | MED |
Eiswirth (Richard S Jr) | Individual Investor | 4.3555 | 322518 | 500 | 2023-04-24 | LOW |
HOOPP Investment Management | Pension Fund | 3.3762 | 250000 | 0 | 2023-03-31 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.0071 | 148624 | 0 | 2023-03-31 | LOW |
Ashman Philip | Individual Investor | 1.8004 | 133315 | 0 | 2023-04-24 | MED |
Holland (David R) | Individual Investor | 1.4704 | 108880 | 500 | 2023-04-24 | LOW |
Renaissance Technologies LLC | Hedge Fund | 1.3693 | 101394 | -1100 | 2023-03-31 | HIGH |
Skibsted (Russell L) | Individual Investor | 1.0196 | 75500 | 58000 | 2023-03-26 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.5167 | 38262 | 0 | 2023-03-31 | LOW |
Jones (John Philip) | Individual Investor | 0.4347 | 32186 | 372 | 2022-10-31 | |
Millennium Management LLC | Hedge Fund | 0.3884 | 28762 | 16799 | 2023-03-31 | HIGH |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 0.2639 | 19542 | 0 | 2023-03-31 | MED |
Bridgeway Capital Management, LLC | Investment Advisor | 0.2471 | 18300 | 0 | 2023-03-31 | LOW |
Perritt Capital Management, Inc. | Investment Advisor | 0.2431 | 18000 | 0 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.175 | 12962 | 438 | 2023-03-31 | LOW |
J.P. Morgan Securities LLC | Research Firm | 0.14 | 10364 | 9838 | 2023-03-31 | MED |
Snisarenko (John) | Individual Investor | 0.135 | 10000 | 0 | 2023-04-24 | LOW |
Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.
Capital.com Group535K+
Trader
87K+
Klien aktif per bulan
$113M+
Volume investasi per bulan
$64M+
Penarikan tiap bulan
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Industry: | Biopharmaceuticals |
Ste 290
6120 Windward Parkway
ALPHARETTA
GEORGIA 30005
US
Income Statement
- Annual
- Quarterly
People also watch
Masih mencari broker yang bisa Anda percayai?
Bergabung dengan 535.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com